tradmap

HCTI Earnings Healthcare Triangle, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$517584 -$176136 $165312 $0 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $23M $46M 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$14M -$6M $2M $0 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$104930 -$52465 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $5M $10M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$6M -$3M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–27 of 27
Q2 20262026-06-30-31.202026-08-1310-Q
Q1 20262026-03-31-136.202026-05-1410-Q
Q4 2025 (derived)2025-12-31-1838.402026-04-1510-K
FY 20252025-12-31-3046.002026-04-1510-K
Q3 20252025-09-30-504.002025-11-1310-Q
Q2 20252025-06-30-700.202025-08-1410-Q
Q1 20252025-03-31-3.402025-05-2010-Q
Q4 2024 (derived)2024-12-31-104930.002025-03-3110-K
FY 20242024-12-31-338186.002025-03-3110-K
Q3 20242024-09-30-65736.002024-11-1410-Q
Q2 20242024-06-30-84864.002024-08-1910-Q
Q1 20242024-03-31-82656.002024-05-2010-Q
Q4 2023 (derived)2023-12-31-82656.002024-03-1810-K
FY 20232023-12-31-409344.002024-03-1810-K
Q3 20232023-09-30-88560.00——
Q2 20232023-06-30-82656.00——
Q1 20232023-03-31-155472.00——
FY 20222022-12-31-517584.00——
Q2 20222022-06-30-19680.002022-08-0810-Q
Q1 20222022-03-31-112176.002022-05-1610-Q
Q4 2021 (derived)2021-12-31-226320.002022-03-0810-K
FY 20212021-12-31-397536.002022-03-0810-K
Q3 20212021-09-30-135792.002021-11-2310-Q
Q2 20212021-06-3019680.00——
Q1 20212021-03-31-55104.00——
FY 20202020-12-31165312.00——
Q3 20202020-09-309840.00——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.